Allergy Therapeutics Selects AGC Biologics to Manufacture Novel Peanut Allergy Vaccine Candidate
March 31, 2022 09:00 ET
|
AGC Biologics
Seattle, March 31, 2022 (GLOBE NEWSWIRE) -- AGC Biologics, a leading global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO), today announced a new partnership with...
AGC Biologics Supports Omicron-based Vaccine Candidate Manufacturing with Starting Material
February 08, 2022 19:00 ET
|
AGC Biologics
Heidelberg, Germany, Feb. 08, 2022 (GLOBE NEWSWIRE) -- AGC Biologics, a leading global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO), today announced an expanded...
AGC Biologics Names Regina Choi-Rivera New General Manager of Boulder, Colorado Mammalian Production Facility
January 18, 2022 09:05 ET
|
AGC Biologics
Boulder, Colo., Jan. 18, 2022 (GLOBE NEWSWIRE) -- AGC Biologics, a leading global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO), today announced Regina Choi-Rivera as...
AGC Biologics Receives Transatlantic Award for Investments in Milan Biopharmaceutical Industry
December 20, 2021 08:05 ET
|
AGC Biologics
Milan, Dec. 20, 2021 (GLOBE NEWSWIRE) -- AGC Biologics, a leading global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO), today announced it has won the 2021...
I-MAB Biopharma and AGC Biologics Partner on Late-Phase Project
December 13, 2021 20:05 ET
|
AGC Biologics
Seattle, Dec. 13, 2021 (GLOBE NEWSWIRE) -- AGC Biologics, a leading global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO), today announced a new partnership with I-MAB...
4TEEN4 Pharmaceuticals Selects AGC Biologics to Manufacture Procizumab
December 01, 2021 09:03 ET
|
AGC Biologics
Seattle, Dec. 01, 2021 (GLOBE NEWSWIRE) -- AGC Biologics, a leading global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO), today announced a new partnership with 4TEEN4...
AGC Biologics Appoints Jean-Baptiste Agnus as Chief Business Officer
November 01, 2021 09:03 ET
|
AGC Biologics
Seattle, Nov. 01, 2021 (GLOBE NEWSWIRE) -- AGC Biologics, a leading global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO), today announced Jean-Baptiste Agnus has been...
AGC Biologics Expands pDNA and mRNA Manufacturing Capacity at Heidelberg Facility
September 13, 2021 19:57 ET
|
AGC Biologics
Heidelberg, Germany, Sept. 13, 2021 (GLOBE NEWSWIRE) -- AGC Biologics, a leading global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO), today announced expansion plans...
AGC Biologics Announces the Groundbreaking of its New Facility at its Copenhagen, Denmark Site
August 20, 2021 13:39 ET
|
AGC Biologics
COPENHAGEN, Aug. 20, 2021 (GLOBE NEWSWIRE) -- AGC Biologics, a leading global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO), announces the groundbreaking of its new...
AGC Biologics Appoints Tony Fraij as the new General Manager/Site Head of the Longmont, Colorado Site
August 09, 2021 13:00 ET
|
AGC Biologics
LONGMONT, Aug. 09, 2021 (GLOBE NEWSWIRE) -- AGC Biologics, a leading global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO), has announced a new leadership appointment...